Management

Jens Hansen
Ph.D

CEO
Inventor of the Rivelin® technology and co-founder of Dermtreat ApS. Previously VP R&D, Dumex-Alpharma, adjunct professor in physical-chemistry – Copenhagen University, VP Pharmaceutical Research and Development and cVP New Products, LEO Pharma. Has brought 7 products to market in USA, Europe and Japan.

jh@rivelin.eu

Keld Søndergaard
HD-F

CFO
Private investor having developed and worked with a number of SMEs – including funding, operations and exit. Previously experienced from large listed companies (AP Moller, FLSmidth and IC Companys), including positions as Group Treasurer and CFO.

ks@rivelin.eu

Lars Siim Madsen
Msc. Ph.D

COO
+15 years experience as drug developer and leader coming from biotech, holding different leading positions as VP and Board of Directors at NeuroSearch and as COO at BioAdvice A/S.

lsm@rivelin.eu